ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,874Medicare Part D Prescriptions Filled, Including Refills

Rank: 71 out of 783

$777K Total Retail Price of All Prescriptions

Rank: 105 out of 783

505 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 505 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 505 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 14,115 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 569 546 1 3
ATENOLOL 553 527 2 17
LEVOTHYROXINE SODIUM 545 538 3 1
OMEPRAZOLE 536 500 4 6
AMLODIPINE BESYLATE 475 462 5 5
FUROSEMIDE 465 443 6 7
LISINOPRIL 436 411 7 4
WARFARIN SODIUM 397 381 8 10
TRAMADOL HCL 388 383 9 20
ALLOPURINOL 277 264 10 31
LOVASTATIN 271 258 11 58
METFORMIN HCL 254 232 12 8
METOPROLOL TARTRATE 243 229 13 9
LOSARTAN POTASSIUM 242 239 14 18
METOPROLOL SUCCINATE 230 225 15 13
PRAVASTATIN SODIUM 226 210 16 14
ISOSORBIDE MONONITRATE ER 193 193 17 40
DOXYCYCLINE HYCLATE 185 171 18 112
LOSARTAN-HYDROCHLOROTHIAZIDE 169 166 19 53
HYDROCHLOROTHIAZIDE 166 158 20 12
SPIRONOLACTONE 161 147 21 57
SERTRALINE HCL 151 151 22 22
CARVEDILOL 145 133 23 21
PANTOPRAZOLE SODIUM 138 124 24 30
ATORVASTATIN CALCIUM 130 125 25 11
POTASSIUM CHLORIDE 129 125 26 16
CARBIDOPA-LEVODOPA 125 120 27 88
PREDNISONE 119 101 28 36
NAMENDA 113 113 29 32
GLIPIZIDE ER 111 95 30 84
ZOLPIDEM TARTRATE 109 105 31 23
SULFAMETHOXAZOLE-TRIMETHOPRIM 106 96 32 95
KLOR-CON M20 104 104 33 48
DIOVAN 99 93 34 49
DONEPEZIL HCL 89 89 35 24
GABAPENTIN 87 85 36 15
AMOX TR-POTASSIUM CLAVULANATE 85 80 37 128
AZITHROMYCIN 84 81 38 41
CIPROFLOXACIN HCL 83 82 39 62
HYDRALAZINE HCL 82 82 40 78
ROPINIROLE HCL 79 79 41 74
PROPRANOLOL HCL 79 76 41 129
DIGOXIN 77 66 43 61
CITALOPRAM HBR 76 75 44 19
LANTUS 72 60 45 38
INSULIN SYRINGE 71 60 46 82
CLOPIDOGREL 69 67 47 29
NOVOLIN 70-30 68 63 48 227
PROAIR HFA 67 64 49 56
FENTANYL 67 65 S2 49 65
ACETAMINOPHEN-CODEINE 66 66 S3 51 144
CLONIDINE HCL 66 65 51 60
TAMSULOSIN HCL 65 65 53 26
MECLIZINE HCL 64 59 54 146
PLAVIX 64 62 54 51
MELOXICAM 64 62 54 37
RAMIPRIL 63 60 57 113
TRIAMTERENE-HCTZ 61 60 58 42
ESCITALOPRAM OXALATE 61 59 58 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 55 60 33
NEXIUM 60 59 60 28
HUMULIN 70-30 60 51 60 211
CLOTRIMAZOLE-BETAMETHASONE 58 56 63 189
LEVEMIR FLEXPEN 58 48 63 155
LUNESTA 57 57 65 290
CYMBALTA 56 52 66 35
DIOVAN HCT 56 56 66 94
PEN NEEDLE 54 54 68 103
ALENDRONATE SODIUM 51 51 69 25
ADVAIR DISKUS 51 48 69 50
SUCRALFATE 51 51 69 190
ALPRAZOLAM 51 51 69 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.